These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug metabolism in experimental tuberculosis: II. Modification of monooxygenase activities due to infection by the administration of isonicotinic acid hydrazide. Batra DK; Venkitasubramian TA; Raj HG Eur J Drug Metab Pharmacokinet; 1987; 12(3):189-92. PubMed ID: 3436341 [TBL] [Abstract][Full Text] [Related]
3. Blood levels of isoniazid in Indian children with tuberculosis. Rangari GM; Roy V; Sethi GR; Mishra TK; Khanna A Indian J Tuberc; 2015 Apr; 62(2):80-5. PubMed ID: 26117476 [TBL] [Abstract][Full Text] [Related]
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
5. [Preventive therapy in middle-aged and elderly persons selected from the population-based screening by mass miniature radiography--methodological aspect and adverse reactions]. Ohmori M; Wada M; Nishii K; Nakazono T; Masuyama H; Yoshiyama T; Inaba K; Itoh K; Uchimura K; Saegusa M; Mitarai S; Kimura M; Shimouchi A Kekkaku; 2002 Oct; 77(10):647-58. PubMed ID: 12440139 [TBL] [Abstract][Full Text] [Related]
6. Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid: differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis. Kang SK; Lee JH; Lee YC; Kim CH Biochim Biophys Acta; 2006 May; 1760(5):724-9. PubMed ID: 16563633 [TBL] [Abstract][Full Text] [Related]
7. Structural Changes in the Lungs and Liver of Mice with Experimental Tuberculosis Treated with Liposome-Encapsulated Dextrazide. Shkurupy VA; Cherdantseva LA; Kovner AV; Troitskii AV; Bystrova TN; Starostenko AA Bull Exp Biol Med; 2020 Mar; 168(5):654-657. PubMed ID: 32246371 [TBL] [Abstract][Full Text] [Related]
8. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045 [TBL] [Abstract][Full Text] [Related]
9. Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases. Tuberculosis Research Centre, Indian Council of Medical Research (ICMR), Chennai, India Int J Tuberc Lung Dis; 2011 Jun; 15(6):782-8. PubMed ID: 21575299 [TBL] [Abstract][Full Text] [Related]
10. Isonicotinic acid hydrazide (INH): A new agent for cervical ripening at term. Haghighi L; Mohabatian B J Obstet Gynaecol; 2015 Apr; 35(3):251-4. PubMed ID: 25244665 [TBL] [Abstract][Full Text] [Related]
11. [Active tuberculosis in children who received INH chemoprophylaxis]. Ikeda K; Sugimori M; Kawasaki K; Kurokawa H; Kijimoto C Kekkaku; 1992 Oct; 67(10):653-8. PubMed ID: 1453566 [TBL] [Abstract][Full Text] [Related]
16. [Isonicotinic acid hydrazide (INH)-induced mental disorders in the course of pulmonary tuberculosis therapy]. Wasik A Psychiatr Pol; 1970; 4(1):17-22. PubMed ID: 5421196 [No Abstract] [Full Text] [Related]
17. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis]. Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137 [TBL] [Abstract][Full Text] [Related]
18. Detection of IgE antibodies specific to isonicotinic acid hydrazide and its metabolite by enzyme-linked immunosorbent assay and the mechanism of sensitization by inhalation or ingestion of this compound. Shimoda T Arerugi; 1990 Jul; 39(7):567-76. PubMed ID: 2073137 [TBL] [Abstract][Full Text] [Related]
19. [On metabolism of isonicotinic acid hydrazide (INH) and alpha-keto acids in tuberculous diabetics]. PFAFFENBERG R; IWAINSKY H; JAEHLER H; SIEGEL D Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 123():63-71. PubMed ID: 13735122 [No Abstract] [Full Text] [Related]
20. Treatment of tuberculosis and other mycobacterial diseases. Am Rev Respir Dis; 1983 Jun; 127(6):790-6. PubMed ID: 6859666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]